0 XP   0   0   0

GKB OPHTHALMICS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell Gkb?

I guess you are interested in GKB OPHTHALMICS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Gkb

Let's start. I'm going to help you getting a better view of GKB OPHTHALMICS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is GKB OPHTHALMICS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how GKB OPHTHALMICS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value GKB OPHTHALMICS LTD.. The closing price on 2023-01-27 was INR189.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
GKB OPHTHALMICS LTD. Daily Candlestick Chart
GKB OPHTHALMICS LTD. Daily Candlestick Chart
Summary









1. Valuation of Gkb




Current price per share

INR189.00

2. Growth of Gkb




Is Gkb growing?

Current yearPrevious yearGrowGrow %
How rich?$7.7m$7.7m$54.5k0.7%

How much money is Gkb making?

Current yearPrevious yearGrowGrow %
Making money$156.7k-$111.6k$268.3k171.2%
Net Profit Margin1.8%-1.6%--

How much money comes from the company's main activities?

3. Financial Health of Gkb




Comparing to competitors in the Medical Instruments & Supplies industry




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#100 / 188

Most Revenue
#63 / 188

Most Profit
#101 / 188

Most Efficient
#115 / 188


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of GKB OPHTHALMICS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gkb earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Gkb to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 1.8% means that ₹0.02 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 1.8%. The company is making a profit. +1
  • The TTM is 1.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY-1.6%+3.4%
TTM1.8%5Y-1.2%+3.0%
5Y-1.2%10Y1.5%-2.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%7.5%-5.7%
TTM1.8%7.3%-5.5%
YOY-1.6%8.7%-10.3%
5Y-1.2%6.8%-8.0%
10Y1.5%7.0%-5.5%
1.1.2. Return on Assets

Shows how efficient Gkb is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gkb to the Medical Instruments & Supplies industry mean.
  • 1.2% Return on Assets means that Gkb generated ₹0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.2%0.0%
TTM1.2%YOY-0.8%+2.0%
TTM1.2%5Y-0.8%+1.9%
5Y-0.8%10Y1.0%-1.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%1.5%-0.3%
TTM1.2%1.4%-0.2%
YOY-0.8%1.5%-2.3%
5Y-0.8%1.2%-2.0%
10Y1.0%1.3%-0.3%
1.1.3. Return on Equity

Shows how efficient Gkb is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gkb to the Medical Instruments & Supplies industry mean.
  • 2.0% Return on Equity means Gkb generated ₹0.02 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY-1.4%+3.5%
TTM2.0%5Y-1.3%+3.4%
5Y-1.3%10Y0.8%-2.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%2.4%-0.4%
TTM2.0%2.6%-0.6%
YOY-1.4%2.9%-4.3%
5Y-1.3%2.3%-3.6%
10Y0.8%2.4%-1.6%

1.2. Operating Efficiency of GKB OPHTHALMICS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gkb is operating .

  • Measures how much profit Gkb makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gkb to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1.1%+1.1%
5Y-1.1%10Y0.8%-1.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.1%-10.1%
TTM-9.8%-9.8%
YOY-10.8%-10.8%
5Y-1.1%7.9%-9.0%
10Y0.8%7.2%-6.4%
1.2.2. Operating Ratio

Measures how efficient Gkb is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.60 means that the operating costs are ₹1.60 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 1.597. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.597. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.597TTM1.5970.000
TTM1.597YOY1.673-0.076
TTM1.5975Y1.653-0.056
5Y1.65310Y1.646+0.007
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5971.172+0.425
TTM1.5971.094+0.503
YOY1.6730.990+0.683
5Y1.6531.046+0.607
10Y1.6461.006+0.640

1.3. Liquidity of GKB OPHTHALMICS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gkb is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.91 means the company has ₹1.91 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 1.905. The company is able to pay all its short-term debts. +1
  • The TTM is 1.905. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.905TTM1.9050.000
TTM1.905YOY1.942-0.036
TTM1.9055Y1.816+0.090
5Y1.81610Y1.737+0.079
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9052.529-0.624
TTM1.9052.586-0.681
YOY1.9422.402-0.460
5Y1.8162.490-0.674
10Y1.7372.359-0.622
1.3.2. Quick Ratio

Measures if Gkb is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gkb to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.67 means the company can pay off ₹0.67 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 0.673. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.673. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.673TTM0.6730.000
TTM0.673YOY0.698-0.025
TTM0.6735Y0.805-0.132
5Y0.80510Y0.826-0.021
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6731.102-0.429
TTM0.6731.064-0.391
YOY0.6981.119-0.421
5Y0.8051.094-0.289
10Y0.8261.026-0.200

1.4. Solvency of GKB OPHTHALMICS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gkb assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gkb to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.43 means that Gkb assets are financed with 42.7% credit (debt) and the remaining percentage (100% - 42.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 0.427. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.427. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.427TTM0.4270.000
TTM0.427YOY0.413+0.014
TTM0.4275Y0.427+0.001
5Y0.42710Y0.435-0.009
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4270.347+0.080
TTM0.4270.341+0.086
YOY0.4130.368+0.045
5Y0.4270.376+0.051
10Y0.4350.372+0.063
1.4.2. Debt to Equity Ratio

Measures if Gkb is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gkb to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 74.6% means that company has ₹0.75 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 0.746. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.746. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.746TTM0.7460.000
TTM0.746YOY0.705+0.041
TTM0.7465Y0.746+0.000
5Y0.74610Y0.502+0.244
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7460.517+0.229
TTM0.7460.520+0.226
YOY0.7050.591+0.114
5Y0.7460.628+0.118
10Y0.5020.632-0.130

2. Market Valuation of GKB OPHTHALMICS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Gkb generates.

  • Above 15 is considered overpriced but always compare Gkb to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 36.72 means the investor is paying ₹36.72 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GKB OPHTHALMICS LTD.:

  • The EOD is 75.443. Neutral. Compare to industry.
  • The MRQ is 36.723. Good. +1
  • The TTM is 36.723. Good. +1
Trends
Current periodCompared to+/- 
EOD75.443MRQ36.723+38.719
MRQ36.723TTM36.7230.000
TTM36.723YOY-45.548+82.271
TTM36.7235Y-24.998+61.722
5Y-24.99810Y-10.231-14.768
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD75.44359.546+15.897
MRQ36.72361.746-25.023
TTM36.72385.285-48.562
YOY-45.54898.197-143.745
5Y-24.99857.263-82.261
10Y-10.23153.213-63.444
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Gkb.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of GKB OPHTHALMICS LTD.:

  • The MRQ is 10.828. Seems overpriced? -1
  • The TTM is 10.828. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ10.828TTM10.8280.000
TTM10.828YOY-30.230+41.058
TTM10.8285Y10.930-0.103
5Y10.93010Y13.536-2.605
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ10.828-0.016+10.844
TTM10.828-0.191+11.019
YOY-30.2300.014-30.244
5Y10.9300.044+10.886
10Y13.5360.101+13.435

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gkb is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 0.74 means the investor is paying ₹0.74 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of GKB OPHTHALMICS LTD.:

  • The EOD is 1.524. Good. +1
  • The MRQ is 0.742. Very good. +2
  • The TTM is 0.742. Very good. +2
Trends
Current periodCompared to+/- 
EOD1.524MRQ0.742+0.782
MRQ0.742TTM0.7420.000
TTM0.742YOY0.660+0.082
TTM0.7425Y0.792-0.050
5Y0.79210Y0.740+0.052
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1.5242.751-1.227
MRQ0.7422.850-2.108
TTM0.7423.702-2.960
YOY0.6604.453-3.793
5Y0.7923.597-2.805
10Y0.7403.186-2.446
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of GKB OPHTHALMICS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.262-0.2620%6.748-104%6.243-104%12.403-102%
Book Value Growth--1.0071.0070%1.057-5%1.065-5%1.070-6%
Book Value Per Share--124.034124.0340%124.2960%112.754+10%97.344+27%
Book Value Per Share Growth--0.9980.9980%1.057-6%1.063-6%1.069-7%
Current Ratio--1.9051.9050%1.942-2%1.816+5%1.737+10%
Debt To Asset Ratio--0.4270.4270%0.413+3%0.427+0%0.435-2%
Debt To Equity Ratio--0.7460.7460%0.705+6%0.746+0%0.502+49%
Dividend Per Share----0%-0%-0%-0%
Eps--2.5052.5050%-1.800+172%-1.412+156%1.266+98%
Eps Growth--3.3923.3920%1.507+125%1.144+196%1.880+80%
Free Cash Flow Per Share--0.6100.6100%-19.820+3348%-9.601+1674%-6.890+1229%
Free Cash Flow Per Share Growth--2.0312.0310%-14.778+828%-1.869+192%-0.645+132%
Free Cash Flow To Equity Per Share---2.662-2.6620%-14.330+438%-2.237-16%-6.373+139%
Free Cash Flow To Equity Per Share Growth--1.8141.8140%-3.077+270%0.852+113%-3.053+268%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max--9.723--------
Intrinsic Value_10Y_min--8.216--------
Intrinsic Value_1Y_max--0.690--------
Intrinsic Value_1Y_min--0.671--------
Intrinsic Value_3Y_max--2.290--------
Intrinsic Value_3Y_min--2.159--------
Intrinsic Value_5Y_max--4.152--------
Intrinsic Value_5Y_min--3.794--------
Net Profit Margin--0.0180.0180%-0.016+189%-0.012+168%0.015+24%
Operating Margin----0%-0%-0.0110%0.008-100%
Operating Ratio--1.5971.5970%1.673-5%1.653-3%1.646-3%
Pb Ratio1.524+51%0.7420.7420%0.660+12%0.792-6%0.740+0%
Pe Ratio75.443+51%36.72336.7230%-45.548+224%-24.998+168%-10.231+128%
Peg Ratio--10.82810.8280%-30.230+379%10.930-1%13.536-20%
Price Per Share189.000+51%92.00092.0000%82.000+12%85.940+7%72.645+27%
Price To Total Gains Ratio-720.636-105%-350.786-350.7860%12.152-2987%-72.109-79%-6.405-98%
Profit Growth--3.4043.4040%1.507+126%1.146+197%1.882+81%
Quick Ratio--0.6730.6730%0.698-4%0.805-16%0.826-19%
Return On Assets--0.0120.0120%-0.008+173%-0.008+166%0.010+19%
Return On Equity--0.0200.0200%-0.014+172%-0.013+166%0.008+164%
Revenue Growth--1.2471.2470%0.973+28%0.999+25%1.089+14%
Total Gains Per Share---0.262-0.2620%6.748-104%6.243-104%12.403-102%
Total Gains Per Share Growth---0.039-0.0390%0.765-105%1.519-103%6.253-101%
Usd Book Value--7760771.1007760771.1000%7706242.986+1%7004789.164+11%6042296.624+28%
Usd Book Value Change Per Share---0.003-0.0030%0.083-104%0.077-104%0.153-102%
Usd Book Value Per Share--1.5261.5260%1.5290%1.387+10%1.197+27%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0310.0310%-0.022+172%-0.017+156%0.016+98%
Usd Free Cash Flow--38179.20038179.2000%-1228806.900+3319%-595207.846+1659%-297603.923+879%
Usd Free Cash Flow Per Share--0.0080.0080%-0.244+3348%-0.118+1674%-0.085+1229%
Usd Free Cash Flow To Equity Per Share---0.033-0.0330%-0.176+438%-0.028-16%-0.078+139%
Usd Price Per Share2.325+51%1.1321.1320%1.009+12%1.057+7%0.894+27%
Usd Profit--156738.900156738.9000%-111616.965+171%-87268.451+156%78608.402+99%
Usd Revenue--8725324.8008725324.8000%6996016.632+25%7905584.240+10%6901146.646+26%
Usd Total Gains Per Share---0.003-0.0030%0.083-104%0.077-104%0.153-102%
 EOD+1 -4MRQTTM+0 -0YOY+20 -185Y+23 -1510Y+26 -14

3.2. Fundamental Score

Let's check the fundamental score of GKB OPHTHALMICS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1575.443
Price to Book Ratio (EOD)Between0-11.524
Net Profit Margin (MRQ)Greater than00.018
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.673
Current Ratio (MRQ)Greater than11.905
Debt to Asset Ratio (MRQ)Less than10.427
Debt to Equity Ratio (MRQ)Less than10.746
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.012
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of GKB OPHTHALMICS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose197.000
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-03-312019-03-312020-03-312021-03-312022-03-31
Income before Tax  -11,364-4,431-15,795-8,711-24,5068,993-15,51334,06218,549
Net Income  -9,707-1,334-11,041-7,355-18,3969,321-9,07521,81812,743
Operating Income  -3,558-20,366-23,9248,303-15,621-3,830-19,45141,24221,791
Net Income from Continuing Operations  -9,707-1,334-11,041-7,355-18,39610,913-7,48326,92119,438
Net Income Applicable to Common Shares  -9,707-1,334-11,041-7,355-18,3969,321-9,07521,81912,744



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,101,575
Total Liabilities470,618
Total Stockholder Equity630,957
 As reported
Total Liabilities 470,618
Total Stockholder Equity+ 630,957
Total Assets = 1,101,575

Assets

Total Assets1,101,575
Total Current Assets755,345
Long-term Assets755,345
Total Current Assets
Cash And Cash Equivalents 58,937
Short-term Investments 6,356
Net Receivables 195,068
Inventory 377,038
Other Current Assets 114,275
Total Current Assets  (as reported)755,345
Total Current Assets  (calculated)751,674
+/- 3,671
Long-term Assets
Property Plant Equipment 260,604
Intangible Assets 41
Other Assets 65,591
Long-term Assets  (as reported)346,230
Long-term Assets  (calculated)326,236
+/- 19,994

Liabilities & Shareholders' Equity

Total Current Liabilities396,403
Long-term Liabilities31,017
Total Stockholder Equity630,957
Total Current Liabilities
Short-term Debt 96,196
Short Long Term Debt 101,382
Accounts payable 255,655
Other Current Liabilities 7,750
Total Current Liabilities  (as reported)396,403
Total Current Liabilities  (calculated)460,983
+/- 64,580
Long-term Liabilities
Long term Debt Total 16,164
Long term Debt 16,164
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)31,017
Long-term Liabilities  (calculated)32,329
+/- 1,312
Total Stockholder Equity
Common Stock50,406
Retained Earnings 580,551
Total Stockholder Equity (as reported)630,957
Total Stockholder Equity (calculated)630,957
+/-0
Other
Capital Stock50,406
Cash and Short Term Investments 65,293
Common Stock Shares Outstanding 5,087
Liabilities and Stockholders Equity 1,101,575
Net Debt 58,609
Net Invested Capital 748,502
Net Working Capital 358,942



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
> Total Assets 
728,000
728,000
750,000
692,066
817,719
829,832
934,332
1,022,528
1,068,185
1,101,575
1,101,5751,068,1851,022,528934,332829,832817,719692,066750,000728,000728,000
   > Total Current Assets 
454,000
434,000
459,000
511,642
626,517
638,183
639,317
727,592
740,032
755,345
755,345740,032727,592639,317638,183626,517511,642459,000434,000454,000
       Cash And Cash Equivalents 
28,000
23,000
32,000
31,108
21,235
21,682
93,268
131,662
60,154
58,937
58,93760,154131,66293,26821,68221,23531,10832,00023,00028,000
       Short-term Investments 
0
0
0
59,805
34,726
3,640
115
120
5,626
6,356
6,3565,6261201153,64034,72659,805000
       Net Receivables 
186,000
211,000
185,000
171,140
247,565
276,806
236,725
250,601
194,756
195,068
195,068194,756250,601236,725276,806247,565171,140185,000211,000186,000
       Inventory 
230,000
194,000
212,000
212,567
308,332
320,144
277,346
304,183
354,111
377,038
377,038354,111304,183277,346320,144308,332212,567212,000194,000230,000
       Other Current Assets 
10,000
5,000
30,000
35,555
12,728
13,136
27,358
35,665
122,123
114,275
114,275122,12335,66527,35813,13612,72835,55530,0005,00010,000
   > Long-term Assets 
0
0
0
0
186,726
191,648
282,864
294,936
328,153
346,230
346,230328,153294,936282,864191,648186,7260000
       Property Plant Equipment 
0
0
0
131,651
173,941
178,255
250,959
255,824
242,361
260,604
260,604242,361255,824250,959178,255173,941131,651000
       Goodwill 
0
0
0
0
7,379
7,379
7,379
7,379
7,379
0
07,3797,3797,3797,3797,3790000
       Long Term Investments 
124,000
151,000
163,000
43,445
27
25
5,294
0
0
0
0005,294252743,445163,000151,000124,000
       Intangible Assets 
0
0
0
722
7,841
7,543
7,543
7,483
7,446
41
417,4467,4837,5437,5437,841722000
       Other Assets 
0
0
0
4,605
9,392
5,824
31,219
20,225
60,334
65,591
65,59160,33420,22531,2195,8249,3924,605000
> Total Liabilities 
378,000
329,000
350,000
243,955
349,869
380,411
386,270
430,016
441,662
470,618
470,618441,662430,016386,270380,411349,869243,955350,000329,000378,000
   > Total Current Liabilities 
343,000
301,000
333,000
226,958
331,247
364,073
371,469
413,840
381,157
396,403
396,403381,157413,840371,469364,073331,247226,958333,000301,000343,000
       Short-term Debt 
154,000
126,000
88,000
71,184
70,512
98,629
140,544
151,163
103,172
96,196
96,196103,172151,163140,54498,62970,51271,18488,000126,000154,000
       Short Long Term Debt 
154,000
126,000
88,000
708
71,190
99,125
140,714
151,646
103,172
101,382
101,382103,172151,646140,71499,12571,19070888,000126,000154,000
       Accounts payable 
106,000
94,000
171,000
116,238
231,763
240,319
211,798
237,701
237,839
255,655
255,655237,839237,701211,798240,319231,763116,238171,00094,000106,000
       Other Current Liabilities 
95,000
85,000
67,000
31,607
13,120
9,250
3,905
10,121
20,542
7,750
7,75020,54210,1213,9059,25013,12031,60767,00085,00095,000
   > Long-term Liabilities 
0
0
0
0
18,621
16,338
14,801
16,176
24,000
31,017
31,01724,00016,17614,80116,33818,6210000
       Long term Debt Total 
0
0
0
1,345
673
170
0
0
10,000
16,164
16,16410,000001706731,345000
       Other Liabilities 
0
0
0
15,652
17,948
16,168
14,801
16,176
0
0
0016,17614,80116,16817,94815,652000
> Total Stockholder Equity
0
0
0
448,111
467,850
449,421
548,062
592,512
626,524
630,957
630,957626,524592,512548,062449,421467,850448,111000
   Common Stock
62,000
62,000
62,000
41,536
41,536
41,536
46,406
50,406
50,406
50,406
50,40650,40650,40646,40641,53641,53641,53662,00062,00062,000
   Retained Earnings Total Equity0000000000
   Accumulated Other Comprehensive Income 0000000000
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
0
34,842
30,001
22,065
54,186
55,033
0
0
0055,03354,18622,06530,00134,842000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue709,376
Cost of Revenue-448,527
Gross Profit260,849260,849
 
Operating Income (+$)
Gross Profit260,849
Operating Expense-684,119
Operating Income21,791-423,270
 
Operating Expense (+$)
Research Development-
Selling General Administrative94,908
Selling And Marketing Expenses-
Operating Expense684,11994,908
 
Net Interest Income (+$)
Interest Income8,591
Interest Expense-11,136
Net Interest Income-9,672-2,545
 
Pretax Income (+$)
Operating Income21,791
Net Interest Income-9,672
Other Non-Operating Income Expenses-
Income Before Tax (EBT)18,54921,791
EBIT - interestExpense = -11,136
12,743
23,879
Interest Expense11,136
Earnings Before Interest and Taxes (ebit)-29,685
Earnings Before Interest and Taxes (ebitda)57,288
 
After tax Income (+$)
Income Before Tax18,549
Tax Provision-24
Net Income From Continuing Ops19,43818,525
Net Income12,743
Net Income Applicable To Common Shares12,744
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-9,672
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
GGRO.TO
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GGRO.TO.

GGRO.TO Daily Candlestick Chart
0RYA.IL
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0RYA.IL.

0RYA.IL Daily Candlestick Chart
USCU.V
1 minute ago

I found you a MACD Bullish Hidden Divergence on the daily chart of USCU.V.

USCU.V Daily Candlestick Chart
CNE.TO
2 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CNE.TO.

CNE.TO Daily Candlestick Chart
BARU.V
3 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of BARU.V.

BARU.V Daily Candlestick Chart
ALVO.IC
11 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ALVO.IC.

ALVO.IC Daily Candlestick Chart
HURA.TO
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HURA.TO.

HURA.TO Daily Candlestick Chart
IGF.NASDAQ
13 minutes ago

I found you a Golden Cross on the daily chart of IGF.NASDAQ.

IGF.NASDAQ Daily Candlestick Chart
IGBH.NYSE ARC
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IGBH.NYSE ARC.

IGBH.NYSE ARC Daily Candlestick Chart
IFGL.NASDAQ
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IFGL.NASDAQ.

IFGL.NASDAQ Daily Candlestick Chart
IEMG.NYSE ARC
13 minutes ago

I found you a Golden Cross on the daily chart of IEMG.NYSE ARC.

IEMG.NYSE ARC Daily Candlestick Chart
IDRV.NYSE ARC
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IDRV.NYSE ARC.

IDRV.NYSE ARC Daily Candlestick Chart
KESAR.BSE
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of KESAR.BSE.

KESAR.BSE Daily Candlestick Chart
SGAMY.PINK
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGAMY.PINK.

SGAMY.PINK Daily Candlestick Chart
RUG.V
16 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of RUG.V.

RUG.V Daily Candlestick Chart
FLRK.LSE
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FLRK.LSE.

FLRK.LSE Daily Candlestick Chart
3BAB.LSE
17 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BAB.LSE.

3BAB.LSE Daily Candlestick Chart
IWSY.OTCQB
18 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of IWSY.OTCQB.

IWSY.OTCQB Daily Candlestick Chart
HITC.PINK
18 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HITC.PINK.

HITC.PINK Daily Candlestick Chart
ENRT.OTCQB
19 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENRT.OTCQB.

ENRT.OTCQB Daily Candlestick Chart
SCOB.NASDAQ
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SCOB.NASDAQ.

SCOB.NASDAQ Daily Candlestick Chart
MDMN.PINK
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MDMN.PINK.

MDMN.PINK Daily Candlestick Chart
TRRE.PINK
20 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of TRRE.PINK.

TRRE.PINK Daily Candlestick Chart
EPWCF.OTCQB
20 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of EPWCF.OTCQB.

EPWCF.OTCQB Daily Candlestick Chart
CSJP.MI
26 minutes ago

I found you a Golden Cross on the daily chart of CSJP.MI.

CSJP.MI Daily Candlestick Chart